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Abstract
Background: The intestinal epithelium is a barrier that composes one of the most immunologically active surfaces of the
body due to constant exposure to microorganisms as well as an infinite diversity of food antigens. Disruption of intestinal
barrier function and aberrant mucosal immune activation have been implicated in a variety of diseases within and outside
of the gastrointestinal tract. With this model in mind, recent studies have shown a link between diet, composition of
intestinal microbiota, and type 1 diabetes pathogenesis. In the BioBreeding rat model of type 1 diabetes, comparison of the
intestinal microbial composition of diabetes prone and diabetes resistant animals found Lactobacillus species were
negatively correlated with type 1 diabetes development. Two species, Lactobacillus johnsonii and L. reuteri, were isolated
from diabetes resistant rats. In this study diabetes prone rats were administered pure cultures of L. johnsonii or L. reuteri
isolated from diabetes resistant rats to determine the effect on type 1 diabetes development.
Methodology/Principal: Findings Results Rats administered L. johnsonii, but not L. reuteri, post-weaning developed type 1
diabetes at a protracted rate. Analysis of the intestinal ileum showed administration of L. johnsonii induced changes in the
native microbiota, host mucosal proteins, and host oxidative stress response. A decreased oxidative intestinal environment
was evidenced by decreased expression of several oxidative response proteins in the intestinal mucosa (Gpx1, GR, Cat). In L.
johnsonii fed animals low levels of the pro-inflammatory cytokine IFNc were correlated with low levels of iNOS and high
levels of Cox2. The administration of L. johnsonii also resulted in higher levels of the tight junction protein claudin.
Conclusions: It was determined that the administration of L. johnsonii isolated from BioBreeding diabetes resistant rats
delays or inhibits the onset of type 1 diabetes in BioBreeding diabetes prone rats. Taken collectively, these data suggest that
the gut and the gut microbiota are potential agents of influence in type 1 diabetes development. These data also support
therapeutic efforts that seek to modify gut microbiota as a means to modulate development of this disorder.
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Introduction
More than 17 bacterial families encompassing 400 to 500
different microbial species can be found in human adults [1].
These commensal bacteria regulate a myriad of host processes and
provide several nutrients to their host and their symbionts within
the microbial community. In healthy individuals these relation-
ships are thought to occur in equilibrium. However, disruption of
this equilibrium may contribute to a variety of conditions
including inflammatory bowel disease and atopy [2]. This
connection is gaining credibility as associations between gut
microbiota and either the risk for or presence of a variety of
specific human diseases is demonstrated [2].
Genetics undoubtedly plays a major role in the development of
type 1 diabetes (T1D), however numerous environmental factors
have been suggested that could trigger genetic susceptibility.
Interactions between the intestinal environment, barrier function,
and immune system have been shown to have a major impact in
the rate of T1D development. We previously proposed a
hypothesis involving a trio of interacting factors that may create
a ‘‘perfect storm’’ for T1D development [3]. These factors include
(i) an aberrant intestinal microbiota [4,5], (ii) a ‘leaky’ intestinal
mucosal barrier [6], and (iii) altered intestinal immune respon-
siveness [7]. In support of this model, modulation of T1D
pathogenesis in animal models has proved successful through early
intervention with a variety of dietary alterations [8]. Indeed, the
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tion of antibiotics [4,5] has strengthened the hypothesis that an
aberrant microbiota could accelerate disease development.
However, studies determining the effects of antibiotics in
modulating disease development have not assessed whether
reduction of what could be considered ‘‘pro-diabetogenic’’ flora,
or alternatively, an overgrowth of protective flora occurs.
In the BioBreeding diabetes prone (BB-DP) model of T1D, rats
spontaneously develop the automimmune disease due to genetic
susceptibility. A previous study reported a culture-independent
analysis of the bacteria in fecal samples collected from Biobreeding
diabetes resistant (BB-DR) and BB-DP rats [10]. Two genera of
bacteria, Lactobacillus and Bifidobacterium, emerged as dominant
groups negatively correlated with the onset of T1D. Further
analysis of the Lactobacillus population within these groups
established that Lactobacillus strains with cinnamoyl esterase
activity, L. johnsonii N6.2 and L. reuteri TD1, were negatively
correlated with T1D development [11].
This report aims to establish whether commensal bacteria
negatively correlated with T1D (i.e., present in BB-DR rats) can
delay or prevent disease onset in BB-DP rats. As proof of concept,
purified L. johnsonii isolated from BB-DR rats were fed to BB-DP
rats. The resulting change in intestinal microbiota composition
was tested for the ability to delay or prevent autoimmunity in BB-
DP rats. A general assessment of the host response to L. johnsonii
administration indicated that the microbe might target an early
signaling pathway conducive to increased levels of interepithelial
junction proteins and mucus secretion, while decreasing oxidative
status and inflammation in the intestine.
Results
Decreased incidence of diabetes in BB-DP rats fed with L.
johnsonii N6.2
Lactobacillus strains isolated from BB-DR rats were administered
to BB-DP rats to analyze their effect on T1D development. L.
reuteri TD1 or L. johnsonii N6.2 suspensions (1610
8 CFU per
animal) were administered individually daily by oral gavage i) pre-
weaning to 1 day old BB-DP rats during mother feeding and ii)
post-weaning to 21 day old BB-DP rats (Fig. 1). The pre-weaning
administration of Lactobacillus did not modify the rate of T1D
development, however the post-weaning administration of L.
johnsonii N6.2 decreased the incidence of T1D compared to the
control animal group (BB-DP, N=10, P,0.1). A more significant
difference was observed when comparing the L. johnsonii N6.2 fed
group to the L. reuteri TD1 fed group (P,0.04). While disease
incidence in L. johnsonii fed animals decreased, the L. reuteri fed
group showed a similar behavior as the control group (Fig. 2). The
delay in T1D onset was specific to L. johnsonii fed animals. As a
result, in the remainder of the study we compared the responses
referring to three groups: (i) L. johnsonii fed group (includes only
healthy animals), (ii) healthy controls, and (iii) diabetic animals
(includes animals from both the diabetic control and L. johnsonii fed
groups that developed T1D).
Administration of L. johnsonii N6.2 modifies the intestinal
microbiota
The impact of L. johnsonii N6.2 feeding on the intestinal
microbiota was determined. Main groups of microorganisms were
cultured at the onset of diabetes in sick animals or after 141 days in
animals that remained healthy. The abundance of specific
bacterial genera was also measured by RT-qPCR. No statistically
significant differences were obtained in the stool culturable
bacterial fractions of Lactobacillus, Bacteroides, or in the total
anaerobe counts (data not shown). Interestingly, a close examina-
tion of the colony morphology on Rogosa plates showed a diversity
of morphologies in the control group while the L. johnsonii and L.
reuteri fed groups showed homogenous colony morphology. These
observations were confirmed by isolation of bacteria (10 per plate
per animal) and sequencing of the 16S RNA gene. In the control
group, the most abundant specie was L. murinus (65% of isolates)
while L. intestinalis (9%), L. reuteri (18%), L. johnsonii (8%) were found
in lower proportions. In the L. johnsonii and L. reuteri fed groups
88% and 92%, respectively corresponded to the inoculated
bacteria in each group while the remaining colonies were
identified as L. murinus. Since these results indicate that
predominant species of Lactobacillus are uniform within groups,
observed differences in diabetes development and intestinal
environment between groups may correlate to observed differ-
ences in intestinal microbiota composition.
Similarly, no significant differences were obtained in RT-qPCR
experiments measuring the concentration of Pseudomonas, Bacteroi-
des, Staphylococcus, Bifidobacterium, Clostridium, Lactobacillus, and
enterobacteria in the ileal and colonic content. However, analysis
of the ileal mucosa unveiled a statistically significant increase in the
Lactobacillus population in all rats that did not developed diabetes,
independent of bacterial administration. On the other hand, a
statistically significant increase in concentration of enterobacteria
was found in all diabetic animals, independent of bacterial
administration (Fig. 3). Since no differences in the microbiota
were obtained in the stool samples, but were statistically significant
in the ileal mucosa, the positive effect of L. johnsonii N6.2 could be
exhibited primarily in the intestinal mucosa.
L. johnsonii N6.2 administration modifies expression of
tight junction proteins
Previous studies have reported lower levels of the major
intercellular tight junction protein claudin-1 and greater intestinal
permeability in the BB animal model before the onset of diabetes
[6]. It has been suggested that early increase in intestinal
permeability in the BB-DP rats may allow unregulated passage
of environmental antigens that could trigger the autoimmune
response culminating in T1D development. To determine if
administration of L. johnsonii N6.2 modified intestinal integrity,
Figure 1. Feeding design using BB-DP animals. Arrows in black mark the time that feeding was started. The dashed line indicates daily feeding.
The dashed box indicates the period in which rats developed T1D associated hyperglycemia.
doi:10.1371/journal.pone.0010507.g001
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examined on hematoxylin and eosin stained slides of distal small
intestine. No morphological differences between the L. johnsonii fed
group, control healthy, or diabetic animals were found in villus
height or width or crypt depth (data not shown). Necrosis was not
observed in any samples. Interestingly, the number of goblet cells
was significantly higher in both healthy controls and L. johnsonii fed
animals when compared to the diabetic group (Fig. 4A, P,0.05).
At the molecular level we measured the expression of genes
encoding claudin-1 and occludin proteins involved in intercellular
tight junction assembly and maintenance in the intestine. The
healthy control and diabetic groups showed low expression of the
sealing claudin-1 and high levels of occludin tight junction related
transmembrane protein compared to the L. johnsonii fed group
(Fig. 4B). Specifically, the feeding of L. johnsonii upregulated the
expression of claudin-1 and decreased the expression of occludin.
Small differences were observed when comparing the healthy
control group to the diabetic animals. Consequently, L. johnsonii
N6.2 feeding could ameliorate the intestinal barrier dysfunction
observed in this animal model.
L. johnsonii decreases the host intestinal oxidative stress
response
Among the destructive effects of reactive oxygen species (ROS)
generated during early intestinal disease development is the
disruption of epithelial tight junctions [12]. The levels of hexanoyl-
lysine, a biomarker for oxidative stress [13], were determined by
ELISA on ileal mucosa and were variable among the animals
tested. However, levels were significantly higher (P,0.05) in
diabetic animals (53621 mM min
21) when compared to L.
johnsonii group and healthy controls (14610 mM min
21).
To determine the specific mechanisms involved, the ileal
mRNA levels of enzymes involved in ROS detoxification pathways
in the host were determined (Fig. 5A). To ease the presentation of
data we illustrated the gene levels in terms of expression in the L.
johnsonii fed group. The value of one represented expression levels
in the L. johnsonii fed group. Of the genes measured, superoxide
dismutase 2 (Sod2), catalase (Cat), glutathione reductase (GR), and
glutathione peroxidase (Gpx1) were induced in diabetic animals
compared the L. johnsonii group. Sod2 and Gpx1 were induced in
the healthy controls compared the L. johnsonii group. Superoxide
dismutase 1 (Sod1) was the exception as it was not modified under
any condition. The expression of Sod2 and Gpx1 was induced in
the diabetic animals (,4.5 fold and ,4 fold, respectively; P,0.05)
and to a lesser extent Cat and GR (,2 and 1.8 fold, respectively).
By comparing the mRNA levels of the healthy (control and L.
johnsonii fed) with diabetic animals two primary responses were
observed: (i) genes negatively correlated with healthy status (Cat
Figure 3. Quantification using real time qPCR of lactobacilli (A)
and enterobacteria (B) from ileal mucosa. The values are
expressed as mean of the percentages from total bacteria determined
from 5 ng of DNA. * indicates significant differences (P,0.05) between
healthy and diabetic animals (N=6 per group).
doi:10.1371/journal.pone.0010507.g003
Figure 2. Kaplan-Meier plot depicting development of T1D in
BB-DP rats. Rats fed A) pre-weaning or B) post-weaning with L.
johnsonii N6.2 (short dashed line), or L. reuteri TD1 (long dashed line)
compared to the PBS fed control (solid line) N=10 per group.
doi:10.1371/journal.pone.0010507.g002
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administration (Sod2 and Gpx1).
ROS lead to the synthesis of nitric oxide by inducible nitric
oxide synthase (iNOS). The mRNA levels of iNOS were
significantly repressed in the L. johnsonii fed group when compared
to diabetic animals as well as healthy controls (,22 fold, Fig. 5A,
P,0.0001). However, western blot analysis showed that iNOS is
reduced in both L. johnsonii fed and healthy control groups (Fig. 5B)
indicating that low levels of iNOS are correlated with the healthy
status of the animals. Repressed expression of Cox2 in the diabetic
group (Fig. 5A, P,0.001) and healthy control group in
comparison to the L. johnsonii group was also observed.
IFNc is an important mediator of inflammatory responses with
pleiotropic effects in the host. It was previously reported that IFNc
induces the expression of iNOS [14] while repressing the
expression of Cox2 [15]. The aim was to determine if a negative
correlation existed between the levels of pro-inflammatory
cytokines, particularly IFNc and TNFa, and the L. johnsonii-
mediated decrease in oxidative stress response in the host. The
mRNA levels of TNFa decreased ,7 fold (P,0.05) between the
healthy and diabetic animals, but no differences between the
healthy control group and L. johnsonii fed group were observed
(Fig. 6). The results indicate that the low expression of TNFa is
correlated with healthy status and not with the administration of
bacteria. The expression of IFNc, on the contrary, was directly
linked to the administration of L. johnsonii. Diabetic animals
exhibited a ,20 fold higher expression (P,0.005) of IFNc
compared to the L. johnsonii fed group. No significant differences
were observed between the healthy controls and diabetic animals
indicating a specific contribution of the probiotic microorganism
to the decrement of the inflammatory response.
Discussion
In this study we report that the administration of L. johnsonii
N6.2 decreased the progression to T1D when administered post-
weaning. Among the possible mechanisms in which Lactobacillus
exerts beneficial effects for the host are: (i) as a physical barrier
inhibiting the passage of inflammatory antigens, (ii) degradation of
Figure 4. Effect of L. johnsonii administered post weaning on
prevalence of goblet cells (A) and on mRNA levels of tight
junction genes (B). Hematoxylin and eosin stained slides of distal
small intestine were examined for morphological changes. (A)
Percentage of goblet cells in the distal small intestine by treatment
group. (B) RT-qPCR analysis of the expression of tight junction genes.
Relative amounts of claudin 1 and occludin were calculated by
subtracting the internal control (b actin) and changes in expression
levels were calculated relative to the value in the L. johnsonii fed group
(expression =1). Grey bars: Relative expression in the healthy control,
Black bars: relative expression in the diabetic animals. The values are
means +S.D. (N=6); * P,0.05;
#P,0.01; **P,0.0001.
doi:10.1371/journal.pone.0010507.g004
Figure 5. Assessment of the oxidative stress response in the
host. (A) RT-qPCR analysis of the expression of genes linked to the
oxidative stress response in the host. Relative amounts of iNOS, Cox2,
Sod1, Sod2, Gpx1, Cat, and GR were calculated by subtracting the
internal control (b actin) and changes in expression levels were
calculated relative to the value in L. johnsonii feed group (expression
=1). Grey bars: relative expression in the healthy control; Black bars:
relative expression in the diabetic animals. The values are means +S.D.
(N=6); *P,0.05; uP,0.01, **P,0.0001. (B) Western blot analysis of iNOS
levels. b-actin was used as internal control.
doi:10.1371/journal.pone.0010507.g005
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anti-inflammatory compounds. In the BB rat model a combination
of all of these mechanisms is possible due to the overly permeable
characteristic of the small intestine [6].
A higher number of goblet cells in the L. johnsonii fed and
healthy control groups was observed when compared to the
diabetic group. Goblet cells constantly produce mucus, which has
a dual role of protecting the mucosa from adhesion of certain
microorganisms while providing an initial binding site, nutrient
source, and matrix on which commensal bacteria can proliferate
[16]. In this study the observed decrease in goblet cells correlated
with the sick status of the animals, which could result in a lower
production of intestinal mucins. Of note, Mack et al. [17] showed
that L. plantarum has a direct effect on intestinal epithelial cells by
inducing secretion of mucins that diminish enteric pathogens
binding to mucosal epithelial cells. The sustained mucus
production present in L. johnsonii and healthy control groups could
prevent damage from enteric pathogens. While a higher number
of goblet cells was associated with all healthy specimens, claudin
expression was specifically induced following feeding of L. johnsonii.
This change in expression indicates a direct effect of the bacteria
on intestinal barrier integrity.
A puzzling result was that the T1D preventative effect of L.
johnsonii was only observed when administration began in the post-
weaning period rather than during pre-weaning. A combination of
scenarios could explain these results. Since the pre-weaning group
received continued L. johnsonii administration throughout the
experiment (Fig.1), the beneficial effects of these bacteria on T1D
development may be dependent on host immune system maturity.
It is possible that the stress generated by very early intervention in
specimen development could offset the balance of microbial
intestinal composition or immune responsiveness.
The difference in prevention capabilities between L. reuteri and
L. johnsonii post-weaning may involve their response to diet
composition as this factor has been shown to be an important
contributor to development of T1D [18,19]. Although the effects
of specific diets have been reported, the mechanisms behind these
effects remain obscure. One possibility is that certain commensal
bacteria such as L. johnsonii exert beneficial effects on the host
intestines by releasing antioxidant compounds through dietary
fiber hydrolysis. The release of antioxidant compounds by
probiotic bacteria is relevant since an enhanced oxidative stress
response triggered by the excessive production of reactive oxygen
species is observed in T1D and other diseases [20,21]. It has been
shown that small doses of antioxidant compounds decrease the
incidence of diabetes in streptozotocin (STZ)-induced diabetic
mice [22]. Also, we have previously reported a negative
correlation between the presence of bacteria able to release
bioactive antioxidant components from phenolic compounds and
the BBDP model [11]. The L. johnsonii N6.2 strain used in this
study possesses two esterases that can release cinnamic acid and
other phenolic compounds with anti-inflammatory properties.
However, the direct role of these enzymes and antioxidant
compounds on T1D pathogenesis requires further investigation.
The oxidative status of the ileal mucosa was assessed by
measuring the mRNA levels of genes involved in the host oxidative
stress response. Compared to the L. johnsonii fed group, genes
encoding Sod2, Gpx1, Cat, and GR were induced in diabetic
animals. However, Gpx1 and Sod2 expression was also induced in
healthy controls compared to the L. johnsonii group. Overall, the
lower level of these markers of oxidative stress in the L. johnsonii
group indicates a more favorable anti-inflammatory environment
in the ileum with lower levels of ROS.
Nitric oxide is a signaling molecule that links inflammation and
the development of T1D. An increased transcription and
translation of the inducible nitric oxide synthase (iNOS) gene
has been associated with T1D development in BB-DP rats
[23,24]. Here, the expression level of iNOS (and its inducing
cytokine, IFNc) was downregulated in the L. johnsonii group
compared to the diabetic control group. Interestingly, the levels
of Cox-2 showed the opposite effect. Cox-2 has been reported to
be mainly induced in activated macrophages and other
inflammatory cells [25]. However, Luo et al. [26] showed that
the presence of Cox-2 in b-cells decreased during progression of
diabetes in the NOD mouse model. In this study, the mRNA
levels of Cox-2 in the ileum increased in the healthy animals with
the highest expression in the L. johnsonii fed group. The increase
in Cox-2 expression observed also correlates with a higher
number of goblet cells in the intestine of healthy rats, in
agreement with Luo et al. [27]. However, these results suggest
that the expression of Cox-2, and its prostaglandin products, may
have a protective effect. Gilroy, Colville-Nash and others [28,29]
have shown that the synthesis of cyclopentenone prostaglandins
are determinant during inflammatory resolution.
In this study, low expression of pro-inflammatory cytokines
IFNc correlated with the administration of L. johnsonii N6.2,
whereas low expression of TNFa correlated with overall healthy
status. These results indicate that the mechanisms involved in T1D
inhibition in this study may be different from the effect mediated
by the general probiotic treatment VSL3. Previous reports in the
NOD model of diabetes have shown that the administration of the
probiotic formulation VSL3 decreased the incidence of T1D
through IL10 immunomodulation [30] and induction of pro-
inflammatory cytokine IFNc.
Is has been suggested that a highly permeable epithelium, or
‘leaky gut’, fails to inhibit the passage of intestinal content antigens.
This inappropriate exposure to antigens may trigger regulatory T-
cells in an autoimmune cascade [3]. We propose that presence of
L. johnsonii N6.2 in the intestinal epithelium helps maintain
epithelial barrier function by increasing mucus and tight junction
protein production while decreasing the effects of ROS. L. johnsonii
may be targeting an early step in the inflammatory signaling
Figure 6. mRNA levels of the pro-inflammatory cytokine genes,
IFNc and TNFa linked to the oxidative stress response in the
host. Relative expression was calculated as previously described
relative to the value in the L. johnsonii feed group (expression =1).
Relative expression in the L. johnsonii feed group (black bars), healthy
control (dark grey bars), and diabetic animals (grey bars). The values are
means +S.D. (N=6); *P,0.05;
#P,0.01.
doi:10.1371/journal.pone.0010507.g006
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reduces the overall oxidative stress.
In summary, this study observed a delay in the onset of T1D as
well as physiological and immunological differences in the gut
which correlated with the presence of Lactobacillus johnsonii N6.2.
Nevertheless, further research is needed to elucidate the intricacies
of the relationship between autoimmune disease, intestinal health,
and gut microbiota.
Materials and Methods
Ethics Statement
All animal work has been approved by the University of Florida
Institutional Review Board (IRB). Animal housing standards were
as prescribed by the Association for Assessment and Accreditation
of Laboratory Animal Care (AAALAC) with two male or female
rats per cage under pathogen-free conditions. All rats were in the
same room at the same temperature and under the same light. All
rats received the same amount of water and food. The weights of
these animals were measured weekly. The analysis indicated that
all animals were gaining weight at the same pace with no
significant discrepancies when healthy.
Bacterial strains
Two bacterial strains: Lactobacillus johnsonii N6.2 or Lactobacillus
reuteri TD1 isolated from BB-DR rats [11] were grown in MRS
broth (REMEL, Lenexa, USA) at 37uC for 16 h. Cells were
centrifuged at 3000 rpm, pellets washed with sterile PBS buffer.
Aliquots containing 10
10 cells ml
21 were stored at 280uC until
used. Cell viability was determined by plate dilution method on
three aliquots after thawing. For feeding experiments, new aliquots
were thawed immediately before administration.
BB-DP rats experimental design
Bacterial strains were administered to BB-DP rats (Biomedical
Research Models, Worcester, MA) to test whether they would delay
or inhibit the onset of T1D. L. reuteri TD1 or L. johnsonii N6.2
suspensions (10
8 CFU) were administered daily by oral gavage i) pre-
weaning to 1 day old BB-DP rats during mother feeding and ii) post-
weaning at 21 days old BB-DP rats. The control group was
administered PBS only. Starting at the age of 60 days, the blood
glucose levels of the animals were taken weekly using a glucose
monitor kit. If the glucose levels were higher than 250 mg/dl for two
consecutive days, then the rat was considered to have developed
diabetes. Once a rat developed diabetes, it was sacrificed, and organs
and tissues were harvested and preserved for analysis. For anatomic
studies, the small intestine was harvested and flushed with phosphate-
buffered saline at 4uC to remove intraluminal contents. The small
intestine was divided into 3 equal sections to demarcate the
duodenum, jejunum and ileum. Small pieces of each section were
fixed in 10% (v/v) neutral buffered formalin for 24 hours for light
microscopy or preserved in RNAlaterH solution (Ambion, Austin,
USA) for RT-qPCR analysis.
Analysis of the intestinal microflora by viability counts
Samples taken from colonic content were immediately placed in
5 ml of sterile PBS buffer. After dilution viable counts were
obtained using MRS (REMEL, Lenexa, USA) adjusted to pH 5.5
for lactobacilli, BBE (BD BBL, Sparks, USA) for Bacteroides and
BHI agar with sheep blood (REMEL, Lenexa, USA) for anaerobes
incubated anaerobically (BD BBL
TM GasPack Plus; Sparks, USA)
for 48 h at 37uC. Enterobacteria counts were determined using
McConkey agar plates (REMEL, Lenexa, USA) incubated under
aerobic conditions at 37uC for 24 h.
Analysis of the intestinal microflora by Real-time
quantification
DNA extractions from samples preserved at 280uCi n
RNAlaterH solution (Ambion, Austin, USA) were perform using
the QIAamp DNA Stool Mini kit (Qiagen Sciences, Maryland,
USA) following the manufacturer’s instructions. We investigated
the most important groups of the rat fecal microbiota using DNA
extracts from each rat as a template for RT-qPCRs using the
primers described on Table 1. Quantitative PCRs were performed
in a reaction volume of 20 ml containing 1x iQ SYBR Green
Supermix (Bio-Rad, Hercules, USA), 200 nM each forward and
reverse primers, and 5 ng of DNA extracted from the stool
samples. DNA concentrations were determined with the Nano-
drop
TM spectrophotometer. Amplification and detection of DNA
were performed in duplicate with the iCycler detection system
(BioRad, Hercules, USA) with optical grade 96-well PCR plates
and optical film. The reaction conditions were 50uC for 2 min and
95uC for 10 min, followed by 45 cycles of 95uC for 15 s and 62uC
for 1 min. Data analysis was conducted with the software supplied
by Bio-Rad (Hercules, USA).
DNA amplification standard curves were constructed using
purified genomic DNA in the range 10 fg to 1 ng of L. reuteri, L.
johnsonii, Staphylococcus sp., Bacteroides dorei and E. coli as previously
described in Roesch et al. [10]. The conversion of the amount
DNA of the different bacterial groups into cell numbers in the stool
samples was determined considering the genome size for each
bacteria and the copy number of the 16S RNA gene as described
by Byun et al. [31] and Matsuda et al. [32].
Intestinal morphology
Intestinal integrity was evaluated by histology. Neutral buffered
formalin (10%, V/V) -fixed ileum samples were embedded in
paraffin; cut into 4 mm sections, mounted on glass slides, and
stained with hematoxylin and eosin (H&E) according to standard
Table 1. Primer sequences based on the 16S rRNA used to
discriminate between different groups of bacteria by RT-
qPCR.
TARGET NAME SEQUENCE SOURCE
Bacteria F_Bact 1369 CGGTGAATACGTTCCCGG [34]
R_Prok 1492 TACGGCTACCTTGTTACGACTT
Lactobacillus F-lacto GAGGCAGCAGTAGGGAATCTTC [35]
R-lacto GGCCAGTTACTACCTCTATCCTTCTTC
Bacteroides AllBac296F GAGAGGAAGGTCCCCCAC [36]
AllBac412R CGCTACTTGGCTGGTTCAG
Clostridium Ccoc 07 GACGCCGCGTGAAGGA [34]
Ccoc 14 AGCCCCAGCCTTTCACATC
Enterobac-
teriaceae
En-lsu-3F TGCCGTAACTTCGGGAGAAGGCA [37]
En-lsu-3R TCAAGGACCAGTGTTCAGTGTC
Pseudomonas PSD7F CAAAACTACTGAGCTAGAGTACG [37]
PSD7R TAAGATCTCAAGGATCCCAACGGCT
Staphylococcus STPYF ACGGTCTTGCTGTCACTTATA [37]
STPYR2 TACACATATGTTCTTCCCTAATAA
Bifidobacterium F-bifido CGCGTCYGGTGTGAAAG [35]
R-bifido CCCCACATCCAGCATCCA
doi:10.1371/journal.pone.0010507.t001
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using a Nikon microscope (Universal Imaging Corp., Westchester,
PA) with an ocular micrometer without the examiner knowing the
group assignment. The intestinal injury was evaluated using a
semiquantitative scoring system ranging from 0 to 4 modified by
Arumugam et al. [33]. Normal mucosa was scored as grade 0.
Epithelial cell damages, including loss of cells and separation of the
epithelial cells from the underlying villus were scored between
grades 1–3, while loss of villus tissue was scored as grade 4.
Intestinal sections were also analyzed for goblet cells per total cells
within a villus. For each animal, counts from 6 villi for each slide in
three different regions of the slide were averaged.
Real-Time qPCR of host responses
DNA and RNA extractions from samples preserved at 280uC
in RNAlaterH solution (Ambion, Austin, USA) were perform using
the Ilustra
TM TriplePrep kit (GE Health care, UK) following the
manufacturer’s instructions. cDNA was synthesized using iS-
criptTM cDNA synthesis kit (Bio-Rad, Hercules, USA) and qRT-
PCR were performed as described above. The primers used are
described in Table 2.
Western Blot analysis of iNOS expression
Protein expression was analyzed using whole cell lysates. Rat ileum
samples were weighed, minced, and disaggregated by incubation at
250 rpm and 37uC in phosphate-buffered saline (1:2, w/v) with
0.25% collagenase. Samples were immediately place on ice and
homogenized by vortexing with glass beads (Sigma Life Science)
containing Complete Mini Protease Inhibitor Cocktail (Roche,
Mannheim Germany). Samples were centrifuged at 13,0006gf o r
10 min at 4uC. Protein concentration was determined by Bradford
method (Bio-Rad Protein Assay). 40 ug of protein per sample was
separated using sodium dodecyl sulfate-polyacrylamide electropho-
resis and transferred onto Nitroplus membranes (MSI, Flanders Ma)
using a semi-dry transfer method. Membranes were blocked for 1 h
in phosphate buffered saline with 0.075% tween 20 (T-PBS) and 5%
milk. Membranes were incubated with mouse anti-iNOS antibody
(1:1000) (Abcam, Cambridge, Ma) or mouse anti- b-actin (1:10,000)
(Abcam, Cambridge, Ma) in T-PBS at 4uCo v e r n i g h t ,a n d
subsequently washed twice in T-PBS for five minutes. Incubation
in horseradish peroxidase-conjugated anti-mouse antibody was
performed for 1 h and signal was detected using enhanced
chemiluminescent system (Amersham Pharmacia Biotech). b-actin
was utilized as an internal control.
Hexanoyl-lys enzyme-linked immunosorbent assay
Relative lipid peroxidation was determined by analyzing
hexanoyl-lys levels by ELISA on rat ileum cell suspensions.
20 mg of each rat ileum sample was finely minced on a cold glass
slide and suspended in 300 ul 1X PBS +0.25% collagenase type I
(Invitrogen, Carlsbad, California). Samples were vortexed vigor-
ously at 5 min intervals while incubating at 37uC for 30 min. Free
cell suspensions were separated from remaining connective tissue
fractions after incubation. Cell concentration was determined by
optical density at 600 nm using a Syngery HT microplate reader
(BioTek Instruments, Winooski, VT) Each sample was split into
Table 2. Primer sequences used to analyze the host response by RT-qPCR.
TARGET NAME SEQUENCE SOURCE
b-actin b-actin Fw TGACAGGTGCAGAAGGAGA [38]
b-actin Rv TAGAGCCACCAATCCACACA
Claudin-1 Cldn-1_Fw AGGTCTGGCGACATTAGTGG [39]
Cldn-1_Rv TGGTGTTGGGTAAGAGGTTG
Occludin Occludin_Fw GCTCAGGGAATATCCACCTATCA [40]
Occludin_Rv CACAAAGTTTTAACTTCCCAGACG
Interferon-c IFNc_Fw AGGATGCATTCATGAGCATCGCC [41]
IFNc_Rv CACCGACTCCTTTTCCGCTTCCT
Tumor Necrosis Factor-a TNF-a_Fw TCTTCTCATTCCTGCTCGTG [42]
TNF-a_Rv GATGAGAGGGAGCCCATTT
Inducible Nitric Oxide Synthase iNOS_Fw CTCACTGTGGCTGTGGTCACCTA [38]
iNOS_Rv GGGTCTTCGGGCTTCAGGTTA
Glutathione Peroxidase 1 GPX1_Fw CGGTTTCCCGTGCAATCAGT [43]
GPX1_Rv ACACCGGGGACCAAATGATG
Catalase CAT_Fw CGACCGAGGGATTCCAGATG [43]
CAT_Rv ATCCGGGTCTTCCTGTGCAA
Glutathione Reductase GR_Fw AGCCCACAGCGGAAGTCAAC [43]
GR_Rv CAATGTAACCGGCACCCACA
Superoxide Dismutase1 SOD1_Fw GCGGTGAACCAGTTGTGGTG [43]
SOD1_Rv AGCCACATTGCCCAGGTCTC
Superoxide Dismutase 2 SOD2_Fw AGCTGCACCACAGCAAGCAC [43]
SOD2_Rv TCCACCACCCTTAGGGCTCA
Cyclooxygenase-2 COX2_Fw CTCTGCGATGCTCTTCCGAG [44]
COX2_Rv AAGGATTTGCTGCATGGCTG
doi:10.1371/journal.pone.0010507.t002
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5000 rpm, and washed with 1 ml 1X PBS twice. Cell pellets
were resuspended in 100 ml of 1X PBS and 100 ml of 1X PBS was
added to the control set, and 100 ml of 1X PBS +2 mg/ml
hexanoyl-lysine monoclonal antibody (JaICA, Shizuoka, Japan)
was added to the experimental set. Samples were incubated at
37uC for 1 hr, followed by two washes in 1X PBS. 100 ul of 1X
PBS +80 ng/ml of peroxidase labeled anti-mouse monoclonal
antibody (Amersham Pharmacia Biotech, Pittsburgh, PA) was
added to both sets and incubated for 1 hr at 37uC. Following
incubation, cells were washed twice and resuspended in 100 ul 1X
PBS. A 20 mM reaction mixture of o-Phenylenediamine (Sigma,
St. Loius, MO) was prepared in a 50 mM phosphate citrate buffer
pH=5 and kept dark. Immediately before reading, 30% H2O2
was added to the reaction mixture for a final concentration of
0.04%. 100 ul of reaction mixture was added to each sample, and
samples were read continuously at 450 nm and 570 nm for
30 min using Syngery HT microplate reader (BioTek Instruments,
Winooski, VT). Specific activity was calculated as the amount of
product (mmol.min
21) and normalized the number of cells. This
assay was performed in triplicate for each sample.
Statistical Analysis
Statistical analysis for significant differences was performed
according to the Student’s t-test for unpaired data or by the
nonparametric Mann–Whitney. Differences with P,0.05 and
lower were considered significant. Data was analyzed by
GraphPad Prism (GraphPad Software, San Diego, USA).
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